These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 16768120

  • 1. [Imaging of NASH].
    Tanimoto A, Tomita K.
    Nihon Rinsho; 2006 Jun; 64(6):1127-32. PubMed ID: 16768120
    [Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma with nonalcoholic steatohepatitis.
    Mori S, Yamasaki T, Sakaida I, Takami T, Sakaguchi E, Kimura T, Kurokawa F, Maeyama S, Okita K.
    J Gastroenterol; 2004 Jun; 39(4):391-6. PubMed ID: 15168253
    [Abstract] [Full Text] [Related]

  • 3. [Diagnostic criteria for non-alcoholic steatohepatitis].
    Hashimoto E.
    Nihon Rinsho; 2006 Jun; 64(6):1025-32. PubMed ID: 16768105
    [Abstract] [Full Text] [Related]

  • 4. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
    Stefano JT, de Oliveira CP, Corrêa-Giannella ML, Soares IC, Kubrusly MS, Bellodi-Privato M, de Mello ES, de Lima VM, Carrilho FJ, Alves VA.
    Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
    [Abstract] [Full Text] [Related]

  • 5. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M, Yu WM, Brown RS, Emond JC, Lefkowitch JH.
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [Abstract] [Full Text] [Related]

  • 6. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.
    Wieckowska A, McCullough AJ, Feldstein AE.
    Hepatology; 2007 Aug; 46(2):582-9. PubMed ID: 17661414
    [Abstract] [Full Text] [Related]

  • 7. Nonalcoholic steatohepatitis.
    Brunt EM.
    Semin Liver Dis; 2004 Feb; 24(1):3-20. PubMed ID: 15085483
    [Abstract] [Full Text] [Related]

  • 8. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ.
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [Abstract] [Full Text] [Related]

  • 9. Natural history of nonalcoholic steatohepatitis.
    Liou I, Kowdley KV.
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
    [Abstract] [Full Text] [Related]

  • 10. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
    Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda H, Taniai M, Tokushige K, Shiratori K.
    J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
    [Abstract] [Full Text] [Related]

  • 11. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG.
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [Abstract] [Full Text] [Related]

  • 12. Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder.
    Ikeda H, Suzuki M, Takahashi H, Kobayashi M, Okuse N, Moriya H, Koike J, Maeyama S, Yotsuyanagi H, Itoh F.
    Pathol Int; 2006 Jan; 56(1):40-5. PubMed ID: 16398679
    [Abstract] [Full Text] [Related]

  • 13. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
    Nugent C, Younossi ZM.
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
    [Abstract] [Full Text] [Related]

  • 14. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
    Lackner C.
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917
    [Abstract] [Full Text] [Related]

  • 15. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
    Cuadrado A, Orive A, García-Suárez C, Domínguez A, Fernández-Escalante JC, Crespo J, Pons-Romero F.
    Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
    [Abstract] [Full Text] [Related]

  • 16. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Serfaty L, Lemoine M.
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
    [Abstract] [Full Text] [Related]

  • 17. From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management.
    Lemoine M, Serfaty L, Capeau J.
    Curr Opin Infect Dis; 2012 Feb; 25(1):10-6. PubMed ID: 22183113
    [Abstract] [Full Text] [Related]

  • 18. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 19. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 20. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease.
    Rubinstein E, Lavine JE, Schwimmer JB.
    Semin Liver Dis; 2008 Nov; 28(4):380-5. PubMed ID: 18956294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.